texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Tobenna Nwizu, M.D.

General Summary

Before going into private practice, Dr. Nwizu was an assistant professor at the Cleveland Clinic, specializing in head and neck and thyroid malignancies. He is published in numerous peer review journals and book chapters, and has served as principal investigator in clinical trials.

Education

  • Residency in Internal Medicine
    John H. Stroger Hospital of Cook County, Chicago, IL
  • Fellowship in Hematology and Oncology
    University of Chicago, Chicago, IL
  • Medical Doctorate
    University of Ibadan, Nigeria

Medical Practice

Other Information

Dr. Nwizu enjoys volunteering and has gone on several medical mission trips around the world with his church. He is an avid snowboarder and enjoys working out and running during his free time.

Accolades & Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Head and Neck Society

Community Service

Research Interest

Publications

  • The prognostic value of pretreatment FDG-PET parameters in HPV-associated oropharynx cancer

    Journal of Radiation Oncology, 2016

  • Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer

    Oral Oncology, 2016

  • Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm

    Anticancer Research, 2016

  • Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11

    Oral Oncology, 2016

  • Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone

    Head and Neck, 2016

Show all Publications
  • Pharmacotherapy of head and neck cancer

    Expert Opinion Pharmacotherapy, 2015

  • Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report

    Anticancer Res., 2015

  • Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy

    JAMA Otolaryngol Head Neck Surg., 2015

  • Early and Severe Radiation Toxicity Associated with Concurrent Sirolimus in an Organ Transplant Recipient with Head and Neck Cutaneous Squamous Cell Carcinoma: A Case Report

    Anticancer Research, 2015

  • Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer

    Head Neck, 2015

  • In Squamous Cell Head and Neck Cancer: Which Platinum

    How much and How Often: Expert Review of Anticancer Therapy, 2014

  • Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx

    Head and Neck, 2013

  • Head and Neck Cancer

    Expert Clinical Perspective on Diagnosis & Management of Cancer Analysis of Controversies & Uncertainties in Cancer, 2013

  • Molecular Biology of Lung Cancer and Therapeutic Implications

    Emerging Cancer Therapeutics, 2012

  • Chemotherapy & Targeted Therapy in Head & Neck Cancer

    Head & Neck Oncology Multidisciplinary Approach to Head & Neck Neoplasms, 2012

  • The role of chemotherapy in locally advanced head and neck squamous cell carcinoma

    Seminars in Radiation Oncology, 2012

  • Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma

    Oral Oncology, 2012

  • Biomarkers in lung cancer

    Advances in Personalized Therapy for Lung Cancer, 2011

  • Crizotinib (PF02341066) as a ALK/MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer

    Drugs of the Future, 2011

  • Pharmacodynamic and Predictive Biomarkers for VEGF and mTOR

    Directed Therapies, 2010